Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Pilar Ballester

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 30, 2021
Serum cholesterol predicts transplant-free survival in cirrhotic patients undergoing transjugular intrahepatic portosystemic shuntMaria Pilar Ballester, Paloma Lluch, Joan Tosca, et al.
Hepatology (Baltimore, Md.)|April 3, 2026
A randomized, open-label, Phase 2a study to assess the safety, pharmacodynamics, and pharmacokinetics of YAQ007 versus rifaximin in cirrhosisMaria Pilar Ballester, Juan Antonio Carbonell-Asins, Ahmed Elshabrawi, et al.
Journal of Hepatology|March 22, 2026
Ammonia measurement in cirrhosis: International Delphi consensus recommendations from ISHENMaria Pilar Ballester, Rocío Gallego-Durán, Shalimar, et al.
Scientific Reports|October 7, 2022
Minimal hepatic encephalopathy is associated to alterations in eye movementsFranc Casanova-Ferrer, Cecilia E García-Cena, Juan-Jose Gallego, et al.
International Journal of Molecular Sciences|June 28, 2023
Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver DiseaseAlessandra Fiorillo, Juan-José Gallego, Franc Casanova-Ferrer, et al.
Journal of Hepatology|June 5, 2023
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosisMaria Pilar Ballester, Thomas H Tranah, Lorenz Balcar, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2022
Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort studyMaria Pilar Ballester, Francisco Mesonero, Pablo Flórez-Diez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 15, 2026
REACT Score, a Novel Scoring System, Improves the Prediction of Non-Elective Readmissions in Patients With Decompensated CirrhosisYolanda Sánchez-Torrijos, Ana Torres-Domínguez, Isabel Carmona, et al.
Journal of Hepatology|June 2, 2023
Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failureBanwari Agarwal, Rafael Bañares Cañizares, Faouzi Saliba, et al.
Gastroenterologia Y Hepatologia|May 6, 2024
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohortCristina Suárez Ferrer, Francisco Mesonero Gismero, Berta Caballol, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 30, 2021
Serum cholesterol predicts transplant-free survival in cirrhotic patients undergoing transjugular intrahepatic portosystemic shuntMaria Pilar Ballester, Paloma Lluch, Joan Tosca, et al.
Hepatology (Baltimore, Md.)|April 3, 2026
A randomized, open-label, Phase 2a study to assess the safety, pharmacodynamics, and pharmacokinetics of YAQ007 versus rifaximin in cirrhosisMaria Pilar Ballester, Juan Antonio Carbonell-Asins, Ahmed Elshabrawi, et al.
Journal of Hepatology|March 22, 2026
Ammonia measurement in cirrhosis: International Delphi consensus recommendations from ISHENMaria Pilar Ballester, Rocío Gallego-Durán, Shalimar, et al.
Scientific Reports|October 7, 2022
Minimal hepatic encephalopathy is associated to alterations in eye movementsFranc Casanova-Ferrer, Cecilia E García-Cena, Juan-Jose Gallego, et al.
International Journal of Molecular Sciences|June 28, 2023
Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver DiseaseAlessandra Fiorillo, Juan-José Gallego, Franc Casanova-Ferrer, et al.
Journal of Hepatology|June 5, 2023
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosisMaria Pilar Ballester, Thomas H Tranah, Lorenz Balcar, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2022
Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort studyMaria Pilar Ballester, Francisco Mesonero, Pablo Flórez-Diez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 15, 2026
REACT Score, a Novel Scoring System, Improves the Prediction of Non-Elective Readmissions in Patients With Decompensated CirrhosisYolanda Sánchez-Torrijos, Ana Torres-Domínguez, Isabel Carmona, et al.
Journal of Hepatology|June 2, 2023
Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failureBanwari Agarwal, Rafael Bañares Cañizares, Faouzi Saliba, et al.
Gastroenterologia Y Hepatologia|May 6, 2024
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohortCristina Suárez Ferrer, Francisco Mesonero Gismero, Berta Caballol, et al.
Pageof 3